These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25811794)

  • 1. Relationships Among Adverse Events, Disease Characteristics, and Demographics in Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin.
    Shaparin N; Slattum PW; Bucior I; Nalamachu S
    Clin J Pain; 2015 Nov; 31(11):983-91. PubMed ID: 25811794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of once-daily gastroretentive gabapentin in patients with postherpetic neuralgia aged 75 years and over.
    Gupta A; Li S
    Drugs Aging; 2013 Dec; 30(12):999-1008. PubMed ID: 24163280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.
    Jensen MP; Irving G; Rauck R; Wallace M; Sweeney M; Vanhove GF
    Clin J Pain; 2013 Sep; 29(9):770-4. PubMed ID: 23370075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastroretentive gabapentin (G-GR) formulation reduces intensity of pain associated with postherpetic neuralgia (PHN).
    Sang CN; Sathyanarayana R; Sweeney M;
    Clin J Pain; 2013 Apr; 29(4):281-8. PubMed ID: 22801243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin: Interaction of Patient Demographics, Disease Characteristics, and Efficacy Outcomes.
    Kantor D; Panchal S; Patel V; Bucior I; Rauck R
    J Pain; 2015 Dec; 16(12):1300-1311. PubMed ID: 26409117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics, efficacy, and tolerability of a once-daily gastroretentive dosage form of gabapentin for the treatment of postherpetic neuralgia.
    Chen C; Han CH; Sweeney M; Cowles VE
    J Pharm Sci; 2013 Apr; 102(4):1155-64. PubMed ID: 23381946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world experience with once-daily gabapentin for the treatment of postherpetic neuralgia (PHN).
    Markley HG; Dunteman ED; Kareht S; Sweeney M
    Clin J Pain; 2015 Jan; 31(1):58-65. PubMed ID: 25076463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
    Rauck RL; Irving GA; Wallace MS; Vanhove GF; Sweeney M
    J Pain Symptom Manage; 2013 Aug; 46(2):219-28. PubMed ID: 23149085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin.
    Mehta N; Bucior I; Bujanover S; Shah R; Gulati A
    Health Qual Life Outcomes; 2016 Apr; 14():54. PubMed ID: 27037091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin: a pooled analysis of adverse events from three clinical trials in patients with postherpetic neuralgia.
    Parsons B; Tive L; Huang S
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):157-62. PubMed ID: 15561647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials.
    Fan H; Yu W; Zhang Q; Cao H; Li J; Wang J; Shao Y; Hu X
    J Clin Pharm Ther; 2014 Aug; 39(4):334-42. PubMed ID: 24806220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
    Wallace MS; Irving G; Cowles VE
    Clin Drug Investig; 2010; 30(11):765-76. PubMed ID: 20818838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin.
    Freeman R; Wallace MS; Sweeney M; Backonja MM
    Pain Med; 2015 Oct; 16(10):2000-11. PubMed ID: 26115203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gabapentin versus nortriptyline in post-herpetic neuralgia patients: a randomized, double-blind clinical trial--the GONIP Trial.
    Chandra K; Shafiq N; Pandhi P; Gupta S; Malhotra S
    Int J Clin Pharmacol Ther; 2006 Aug; 44(8):358-63. PubMed ID: 16961166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin for Chronic Neuropathic Pain.
    Moore A; Derry S; Wiffen P
    JAMA; 2018 Feb; 319(8):818-819. PubMed ID: 29486015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
    Gore M; Sadosky A; Tai KS; Stacey B
    Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of gabapentin enacarbil vs placebo in patients with postherpetic neuralgia and a pharmacokinetic comparison with oral gabapentin.
    Backonja MM; Canafax DM; Cundy KC
    Pain Med; 2011 Jul; 12(7):1098-108. PubMed ID: 21627766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of gabapentin for treatment of postherpetic neuralgia: a meta-analysis of randomized controlled trials.
    Meng FY; Zhang LC; Liu Y; Pan LH; Zhu M; Li CL; Li YW; Qian W; Liang R
    Minerva Anestesiol; 2014 May; 80(5):556-67. PubMed ID: 24257149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
    Irving G; Jensen M; Cramer M; Wu J; Chiang YK; Tark M; Wallace M
    Clin J Pain; 2009; 25(3):185-92. PubMed ID: 19333167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of low dose gabapentin in acute herpes zoster for preventing postherpetic neuralgia: a prospective controlled study.
    Lee EG; Lee HJ; Hyun DJ; Min K; Kim DH; Yoon MS
    Dermatol Ther; 2016 May; 29(3):184-90. PubMed ID: 26799145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.